Ultrasound-Controlled CRISPR/Cas9 System Augments Sonodynamic Therapy of Hepatocellular Carcinoma
Main Authors: | Haohao Yin, Liping Sun, Yinying Pu, Jifeng Yu, Wei Feng, Caihong Dong, Bangguo Zhou, Dou Du, Yan Zhang, Yu Chen, Huixiong Xu |
---|---|
Format: | Article |
Language: | English |
Published: |
American Chemical Society
2021-12-01
|
Series: | ACS Central Science |
Online Access: | https://doi.org/10.1021/acscentsci.1c01143 |
Similar Items
-
Design of a self-driven probiotic-CRISPR/Cas9 nanosystem for sono-immunometabolic cancer therapy
by: Jifeng Yu, et al.
Published: (2022-12-01) -
DL-CRISPR : a deep learning method for off-target activity prediction in CRISPR/Cas9 with data augmentation
by: Zhang, Yu, et al.
Published: (2021) -
DL-CRISPR: A Deep Learning Method for Off-Target Activity Prediction in CRISPR/Cas9 With Data Augmentation
by: Yu Zhang, et al.
Published: (2020-01-01) -
CRISPR/Cas9 genetic screens in hepatocellular carcinoma gene discovery
by: Cynthia H. Chiu
Published: (2023-01-01) -
Emerging nanosonosensitizers augment sonodynamic-mediated antimicrobial therapies
by: Qinglin Xu, et al.
Published: (2023-04-01)